Publication & Citation Trends
Most Cited Works
Publications
189 total
FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review PDF
Cited by 68
OpenAlex
Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody
Cited by 64
OpenAlex
Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms PDF
Cited by 402
OpenAlex
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy PDF
Cited by 122
OpenAlex
Inhibition of HSP90 overcomes resistance to chemotherapy and radiotherapy in pancreatic cancer PDF
Cited by 64
OpenAlex
Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy PDF
Cited by 63
OpenAlex
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma PDF
Cited by 377
OpenAlex
Research Topics
Pancreatic and Hepatic Oncology Research
(47)
Colorectal Cancer Treatments and Studies
(39)
Neuroendocrine Tumor Research Advances
(27)
Cholangiocarcinoma and Gallbladder Cancer Studies
(27)
Cancer Genomics and Diagnostics
(24)
Frequent Co-Authors
Affiliations
Yale New Haven Hospital
Emory Healthcare
Emory University
Emory University Hospital
Cancer Institute (WIA)